The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?

Author： Lillie Elizabeth O Patay Bradley Diamant Joel Issell Brian Topol Eric J Schork Nicholas J

ISSN： 1741-0541

Source： Personalized Medicine, Vol.8, Iss.2, 2011-03, pp. : 161-173

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluating the Utility of a ‘N-of-1' Precision Cancer Medicine Strategy: The Case for ‘Time-to-Subsequent-Disease Progression'

Oncology, Vol. 91, Iss. 6, 2016-10 ,pp. : 299-301

Karger

Access to resources Recommend Favorite

An N-of-1 Trial as an Individualized Withdrawal Treatment Approach to Psychological Methylphenidate Dependence

Psychotherapy and Psychosomatics, Vol. 83, Iss. 6, 2014-10 ,pp. : 379-381

Karger

Access to resources Recommend Favorite

Does personalized medicine exist and can you test it in a clinical trial?

INTERNATIONAL JOURNAL OF STROKE, Vol. 10, Iss. 7, 2015-10 ,pp. : 994-999

John Wiley & Sons Inc

Access to resources Recommend Favorite

Axillary lymph node dissection versus no dissection in patients with T1N0 breast cancer: A randomized clinical trial (INT09/98)

CANCER, Vol. 120, Iss. 6, 2014-03 ,pp. : 885-893

John Wiley & Sons Inc

Access to resources Recommend Favorite

Joint Commission Standards Are "Good Medicine" for H1N1

Joint Commission: The Source, Vol. 8, Iss. 1, 2010-01 ,pp. : 3-4

Joint Commission Resources

Access to resources Recommend Favorite